Uttenreuther-Fischer, M M <br/><br/>
Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Jul 1995 
 - 29-36 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF01788957  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Age Factors<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Child<br/>Dose-Response Relationship, Immunologic<br/>Female<br/>Gangliosides--immunology<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Neuroblastoma--therapy<br/>Osteosarcoma--therapy